In this systematic review, we addressed this gap by examining the impacts of RPM interventions on patient safety, adherence, clinical and quality of life outcomes and cost-related
Regardless of the evaluation method used, 44 of the 61 selected studies (72 percent) concluded that remote patient monitoring was reported to be
The cost-effectiveness, from a payer''s viewpoint, of five monitoring strategies was evaluated for patients in low-, medium-, and high-risk groups: (i) remote monitoring technology scheduling follow-up visits
As more countries embrace remote monitoring technologies amid the pandemic, further studies are essential to assess their safety, clinical impact, quality of life, and cost-effectiveness
Introduction The objective of this study is to conduct an assessment of Remote Patient Monitoring (RPM) systems compared to usual care for controlling glycosylated hemoglobin in type 2...
We performed a scoping review of studies published in PubMed, Embase, and Web of Science that conducted an economic evaluation of a remote patient monitoring between January
Cost-effectiveness analyses of mobile device-based active remote monitoring strategies need to show how frequent and sustained user responses to self-reported questions about a long
Advances in mobile apps, remote sensing, and big data have enabled remote monitoring of mental health conditions, but the cost
Conclusions: Remote fetal monitoring seems to reduce the incidence of neonatal asphyxia and health care costs compared with routine fetal monitoring.
142-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on
Remote monitoring includes remote physiologic monitoring (RPM), whereby a patient''s physical data — such as their weight, blood glucose, or blood pressure measurements — are sent to a clinician for
This review demonstrated that RPM can be cost-effective for chronic disease management, although the cost-effectiveness is dependent on capital investment, clinical context,
Cost-effectiveness data on the remote monitoring (RM) of implantable cardioverter-defibrillators (ICDs) compared to the current standard of care (SC) remains limited. This meta
The hybrid model combining remote monitoring with on-site monitoring of clinical trials can reduce monitoring frequency, improve monitoring efficiency, save costs, improve monitoring quality, and
Conclusion: The MONITOR HF trial will evaluate the efficacy and cost-effectiveness of haemodynamic monitoring by CardioMEMS in addition to standard HF care in patients with chronic HF.
This work assesses the cost and the cost-effectiveness of a telemonitoring and tele-education program that routinely gathers data on weight, physical activity and diet in addition to
Non-invasive remote patient monitoring (RPM) interventions have the potential to prevent disease worsening. However, the long-term cost
Results: Considering the incremental cost-effectiveness ratio in the base-case model and in comparison with routine treatment of type 2 diabetes, remote type 2 diabetes monitoring system
Results: The model projects RT-CGM users to have higher quality-adjusted life years by 0.769 with incremental costs of $16,019, and an incremental cost-effectiveness ratio (ICER) of 20,825, which is
Conclusions: Economic evaluations of RPM show mixed cost-effectiveness results. Key limitations include inconsistent cost methodologies and inadequate adherence to reporting
Telemedicine programs using health technological innovation to remotely monitor the lifestyles of patients with type 2 diabetes (T2D) can improve glycaemic control and thus reduce the incidence of
We Look Forward to Working with You